Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chatenoud

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
Clinical Transplantation|August 1, 1993
Immunologic monitoring during OKT3 therapyL Chatenoud
Transplantation Proceedings|February 1, 1997
Biological immunosuppressants: the way to clinical transplantation toleranceL Chatenoud
La Revue Du Praticien|October 6, 2000
[Immunotolerance and autoimmunity]L Chatenoud
Diabetologia|May 31, 2001
Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in established diabetes and islet transplantationL Chatenoud
Immunology Today|October 8, 2014
The immune response against therapeutic monoclonal antibodiesL Chatenoud
Transplantation Proceedings|April 1, 1993
OKT3-induced cytokine-release syndrome: prevention effect of anti-tumor necrosis factor monoclonal antibodyL Chatenoud
Transplantation Proceedings|April 1, 1993
Humoral immune response against OKT3L Chatenoud
European Cytokine Network|November 1, 1992
Allograft rejection: the role of the cytokine networkL Chatenoud
Transplantation Proceedings|December 1, 1994
Use of CD3 antibodies in transplantation and autoimmune diseasesL Chatenoud
Current Directions in Autoimmunity|September 25, 2001
Immunotherapy of type 1 diabetes mellitusL Chatenoud
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
Clinical Transplantation|August 1, 1993
Immunologic monitoring during OKT3 therapyL Chatenoud
Transplantation Proceedings|February 1, 1997
Biological immunosuppressants: the way to clinical transplantation toleranceL Chatenoud
La Revue Du Praticien|October 6, 2000
[Immunotolerance and autoimmunity]L Chatenoud
Diabetologia|May 31, 2001
Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in established diabetes and islet transplantationL Chatenoud
Immunology Today|October 8, 2014
The immune response against therapeutic monoclonal antibodiesL Chatenoud
Transplantation Proceedings|April 1, 1993
OKT3-induced cytokine-release syndrome: prevention effect of anti-tumor necrosis factor monoclonal antibodyL Chatenoud
Transplantation Proceedings|April 1, 1993
Humoral immune response against OKT3L Chatenoud
European Cytokine Network|November 1, 1992
Allograft rejection: the role of the cytokine networkL Chatenoud
Transplantation Proceedings|December 1, 1994
Use of CD3 antibodies in transplantation and autoimmune diseasesL Chatenoud
Current Directions in Autoimmunity|September 25, 2001
Immunotherapy of type 1 diabetes mellitusL Chatenoud
Pageof 26